To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Low-level laser therapy accelerates clinical recovery in chronic Achilles tendinopathy

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
March 2013

Low-level laser therapy accelerates clinical recovery in chronic Achilles tendinopathy

Vol: 2| Issue: 2| Number:267| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Effects of Low-Level Laser Therapy and Eccentric Exercises in the Treatment of Recreational Athletes With Chronic Achilles Tendinopathy

Am J Sports Med. 2008 May;36(5):881-7. Epub 2008 Feb 13.

Contributing Authors:
A Stergioulas M Stergioula R Aarskog RA Lopes-Martins JM Bjordal

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

52 recreational athletes with chronic Achilles tendinopathy symptoms, on an eccentric exercise (EE) regimen, were randomized to receive an 8 week treatment with either a low-level laser therapy (LLLT) or a placebo LLLT. LLLT use in this study has been found to accelerate the clinical recovery in chronic Achilles tendinopathy when added to the EE regimen. The LLLT treatment achieved same results at...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue